Best Supplements to Help with Chronic Fatigue (ME/CFS)

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multi-system illness characterized by profound fatigue that is not improved by rest, post-exertional malaise (PEM), cognitive dysfunction, and often orthostatic intolerance. It is not the same as general fatigue or burnout—and the distinction matters enormously for what interventions are appropriate.

This article focuses on ME/CFS and chronic fatigue in the clinical sense. Some of these supplements are also valuable for general fatigue and burnout. However, for ME/CFS specifically, the approach must account for PEM—the pathological worsening of symptoms following exertion that is the hallmark of this condition.

There is no supplement that cures ME/CFS. But several compounds address the core pathophysiological features—mitochondrial dysfunction, depleted antioxidant capacity, impaired energy metabolism, and nutrient deficiencies that amplify symptoms. Used thoughtfully, they can meaningfully reduce symptom burden.

The evidence-based options

1. CoQ10 (Coenzyme Q10)

Mitochondrial dysfunction is one of the most consistently documented features of ME/CFS. Multiple studies have identified impaired electron transport chain function, reduced ATP production, and oxidative stress in ME/CFS patients. CoQ10 is a critical component of the electron transport chain and a potent antioxidant that directly addresses this.

Mechanism: CoQ10 is essential for electron transfer in complexes I, II, and III of the mitochondrial electron transport chain. Without adequate CoQ10, ATP production is impaired. CoQ10 also serves as a lipid-soluble antioxidant, protecting mitochondrial membranes from oxidative damage. Studies have found CoQ10 levels are significantly lower in ME/CFS patients' plasma and mononuclear cells compared to healthy controls.

Evidence: A 2009 study found CoQ10 blood levels inversely correlated with fatigue severity in ME/CFS. A clinical trial using a combination of NADH and CoQ10 showed significant improvements in peak VO2 (exercise capacity) and fatigue scores in ME/CFS patients. A 2015 randomized trial showed 200mg CoQ10 plus NADH reduced fatigue and improved cognitive function over 8 weeks.

Dosage: 200-400mg ubiquinol daily (the reduced, active form of CoQ10). Ubiquinol is 2-4x more bioavailable than ubiquinone, particularly in older individuals. Take with the largest meal of the day—CoQ10 is fat-soluble.

Note: CoQ10 production declines with age and is depleted by statin medications. If you are on statins, CoQ10 deficiency is near-certain and supplementation is particularly important.

2. Magnesium

Magnesium deficiency in ME/CFS is well-documented and has particular clinical significance. A landmark 1991 study published in The Lancet found red blood cell magnesium levels were significantly lower in ME/CFS patients than healthy controls, and that magnesium injections produced significant clinical improvement.

Mechanism: Magnesium is a cofactor in over 300 enzymatic reactions, including every step of ATP synthesis. Without magnesium, mitochondrial energy production is directly impaired. Magnesium also modulates NMDA receptors (reducing neurological hyperexcitability that contributes to cognitive symptoms), supports muscle relaxation, and is required for normal immune cell function.

Evidence: The 1991 Lancet study remains significant—patients receiving IM magnesium sulfate injections showed significant improvement in energy, pain, and emotional state compared to saline controls. Subsequent studies on oral magnesium in ME/CFS populations have shown mixed results, partly because absorption varies considerably between individuals and formulations.

Dosage: 400-600mg elemental magnesium daily as magnesium glycinate or magnesium malate. Malate is particularly relevant in fatigue conditions—malic acid is a substrate in the Krebs cycle and may support mitochondrial energy production independently. For severe deficiency or poor oral absorption, discuss injectable magnesium with your physician.

Important: Magnesium can cause loose stools at higher doses. If bowel tolerance is an issue, divide doses (morning and evening) or reduce until tolerated, then build gradually.

3. Vitamin B12 (Methylcobalamin)

B12 is critical for neurological function, myelin synthesis, DNA methylation, and the conversion of homocysteine to methionine. ME/CFS patients often show functional B12 deficiency even with normal serum B12 levels.

Mechanism: Functional B12 deficiency impairs methionine synthesis, increasing homocysteine and reducing SAM-e (S-adenosylmethionine), the body's universal methyl donor. This disrupts neurotransmitter synthesis, gene expression, and mitochondrial function. Neurological B12 deficiency manifests as fatigue, cognitive dysfunction, and peripheral neurological symptoms—all core features of ME/CFS.

Evidence: High-dose B12 (particularly hydroxocobalamin or methylcobalamin) has been used in ME/CFS for decades with anecdotal clinical support. A Swedish physician group published observational data on high-dose B12 injections producing significant improvement in a subset of patients. Formal RCT evidence is limited, but the biological plausibility and safety profile support supplementation.

Dosage for ME/CFS: 1000mcg methylcobalamin sublingually daily, or hydroxocobalamin injections if under physician supervision. Sublingual delivery bypasses absorption issues in the gut. The high dose (1000mcg) is safe and appropriate given that ME/CFS may involve impaired B12 utilization even beyond standard absorption issues.

Testing: Check serum B12, methylmalonic acid (MMA), and homocysteine. MMA elevation with normal serum B12 indicates functional intracellular deficiency.

4. D-Ribose

D-ribose is a five-carbon sugar and the structural backbone of ATP. It is also a substrate for the nucleotide biosynthesis pathway, meaning it directly supports the cellular machinery of energy production.

Mechanism: In ME/CFS, energy depletion at the cellular level is thought to persist because the ATP replenishment pathway (specifically the de novo and salvage synthesis of adenine nucleotides) is impaired. D-ribose bypasses rate-limiting steps in this synthesis, providing the molecular building block for ATP regeneration more rapidly than the body produces it.

Evidence: A 2006 pilot study (Journal of Alternative and Complementary Medicine) treated 41 patients with fibromyalgia and/or ME/CFS with 5g D-ribose three times daily. Mean energy improved by 45%, sleep quality by 30%, mental clarity by 30%, pain intensity by 16%, and overall well-being by 30%. This was an open-label trial without placebo control—important limitation—but the magnitude of effect and consistency of response is notable. Larger controlled trials are needed.

Dosage: 5g three times daily (15g total). Mix in water or juice. D-ribose is a sugar and slightly sweet. Can be taken with meals. Start at 5g once daily and build up over 1-2 weeks to allow GI adjustment.

Note: D-ribose can transiently lower blood glucose—eat something if you experience lightheadedness after doses.

5. NADH (Nicotinamide Adenine Dinucleotide)

NADH is the reduced (active) form of NAD+, which is the central electron carrier in cellular energy metabolism. ME/CFS patients have shown reduced NAD+/NADH ratios and impaired mitochondrial function. NADH supplementation provides a direct boost to cellular energy capacity.

Mechanism: NADH donates electrons to Complex I of the mitochondrial electron transport chain, directly driving ATP synthesis. NADH also supports neurotransmitter synthesis (dopamine, norepinephrine, serotonin) and is an antioxidant.

Evidence: A 1999 double-blind crossover RCT (Annals of Allergy, Asthma & Immunology) showed 10mg stabilized oral NADH significantly improved fatigue in ME/CFS patients over 4 weeks. The NADH+CoQ10 combination trial cited above (2015) showed superior outcomes compared to either alone, suggesting complementary mechanisms.

Dosage: 10-20mg stabilized NADH daily. Take on an empty stomach in the morning—NADH is sensitive to stomach acid. The key word is "stabilized"—unstabilized NADH degrades rapidly in the gut. Products from established manufacturers specifically formulated for stability are necessary.

Alternative: NMN (nicotinamide mononucleotide) or NR (nicotinamide riboside) are precursors that support intracellular NAD+ levels via a different pathway. Some ME/CFS patients find these more convenient and well-tolerated than NADH directly.

6. L-Carnitine

L-carnitine shuttles long-chain fatty acids into mitochondria for beta-oxidation (fat burning for energy). Carnitine deficiency causes mitochondrial dysfunction and fatigue that closely resembles ME/CFS symptoms.

Mechanism: Without adequate carnitine, long-chain fatty acids accumulate outside mitochondria, impairing fat-based energy production. Acetyl-L-carnitine (ALCAR), the acetylated form, additionally crosses the blood-brain barrier and serves as an acetyl group donor for acetylcholine synthesis and mitochondrial function in the brain.

Evidence: A 2004 study found lower plasma carnitine levels in ME/CFS patients compared to controls. Multiple small trials using carnitine (both L-carnitine and acetyl-L-carnitine) have shown reductions in fatigue severity. A comparison trial found acetyl-L-carnitine and amantadine comparably effective for fatigue in ME/CFS.

Dosage: 1-2g L-carnitine daily (as L-carnitine tartrate for general energy support), or 500-1000mg acetyl-L-carnitine for combined energy and cognitive support. Take in the morning—carnitine can be activating. Build up from 500mg to reduce GI side effects.

Note: Carnitine may have some influence on TMAO production (a cardiovascular risk marker) via gut microbiome interaction. This is an area of ongoing research; current evidence does not suggest clinically significant risk at supplemental doses, but is worth noting.

7. Omega-3 Fatty Acids (EPA/DHA)

ME/CFS involves immune dysregulation and low-grade neuroinflammation. Omega-3 fatty acids are the most evidence-backed nutritional modulators of inflammatory signaling, and their neurological anti-inflammatory effects are particularly relevant.

Mechanism: EPA and DHA are incorporated into cell membranes and serve as precursors to specialized pro-resolving mediators (SPMs)—resolvins, protectins, and maresins—that actively resolve inflammation. High EPA content reduces pro-inflammatory eicosanoid production from arachidonic acid (the omega-6 fatty acid that drives inflammation when in excess).

Evidence: A 2003 study found significantly lower omega-3 and higher omega-6 fatty acids in ME/CFS patients compared to healthy controls, suggesting impaired fatty acid metabolism. While direct omega-3 RCTs in ME/CFS are limited, the inflammatory profile of ME/CFS and the general evidence for omega-3 in neuroinflammatory and immunological conditions support supplementation.

Dosage: 2-4g EPA+DHA daily. Use high-EPA formulas (EPA:DHA ratio of 2:1 or higher) given EPA's greater anti-inflammatory activity. Take with the largest meal for optimal absorption.

8. Vitamin D

Vitamin D deficiency is significantly more prevalent in ME/CFS patients than in the general population, and deficiency amplifies fatigue, immune dysfunction, pain, and mood disturbances.

Mechanism: Vitamin D modulates immune function (including the regulatory T-cell activity involved in ME/CFS immune dysregulation), regulates inflammatory cytokine production, and influences mitochondrial function via nuclear receptors in mitochondria.

Evidence: A systematic review found vitamin D deficiency is associated with worse ME/CFS symptoms. While correcting deficiency does not cure ME/CFS, multiple patients report meaningful symptom improvement after deficiency correction.

Dosage: Test first. Target 60-80 ng/mL (150-200 nmol/L). Most adults with ME/CFS need 3,000-5,000 IU D3 daily with K2. Retest after 3 months.

Post-exertional malaise (PEM): the critical concept

This section is essential for anyone with ME/CFS.

PEM is a pathological worsening of symptoms—fatigue, cognition, pain, and all other ME/CFS symptoms—typically occurring 12-48 hours after physical or cognitive exertion, and lasting days to weeks. It is the defining feature that distinguishes ME/CFS from other fatigue conditions.

PEM has profound implications for supplementation and activity:

• Do not pursue "exercise therapy" or graded exercise that pushes beyond your energy envelope. The historical recommendation of graded exercise therapy (GET) for ME/CFS has been removed from clinical guidelines in many countries after evidence showed it could worsen the condition.
• Supplements cannot prevent PEM or allow you to safely exceed your energy envelope. CoQ10, D-ribose, and NADH may increase available cellular energy, but PEM is a physiological response, not simply an energy depletion issue.
• Introduce supplements one at a time. New supplements can cause symptom fluctuations that are difficult to interpret if multiple are started simultaneously.
• Energy management (pacing) is more important than any supplement. Heart rate monitoring to stay below the anaerobic threshold is a practical pacing tool.

Building your stack

Start conservative. ME/CFS patients are often sensitive to new supplements. Begin with:

Week 1-2: Magnesium glycinate or malate 200mg (build to 400mg) + Vitamin D correction Week 3-4: CoQ10 200mg ubiquinol Week 5-6: Methylcobalamin 1000mcg sublingual Week 7-8: Omega-3 2-4g Week 9-10: D-ribose 5g once daily (build to 3x/day over 2-3 weeks) Week 11-12: NADH 10mg (fasted morning) Week 13+: Acetyl-L-carnitine 500mg (if tolerated)

Keep a detailed symptom log. PEM can be delayed and may be confused with supplement reactions if you're changing multiple variables simultaneously.

When to see a doctor

ME/CFS requires a physician familiar with the condition. Many general practitioners lack training in ME/CFS management. Seek care if:

• Profound fatigue has persisted for 6+ months
• You experience clear PEM (symptom crash after exertion)
• You have not been evaluated for conditions that mimic ME/CFS: thyroid disorders, adrenal insufficiency, sleep apnea, autoimmune conditions, Lyme disease, and viral illnesses (including long COVID)
• Your functioning has significantly declined from your prior baseline
• Mood disturbances are significant—depression and anxiety commonly co-occur with ME/CFS and are treatable

An infectious disease specialist, rheumatologist, or ME/CFS-specialized clinic may be appropriate depending on your clinical presentation.

The bottom line

CoQ10, magnesium, and high-dose methylcobalamin are the three supplements with the most direct relevance to ME/CFS pathophysiology and the most clinical support. D-ribose and NADH address ATP regeneration through different, complementary mechanisms. Omega-3 fatty acids and vitamin D address the inflammatory and immune components. All supplementation should occur alongside careful energy management—pacing remains the most important functional intervention in ME/CFS, and no supplement replaces it.

---

Track your supplement stack and monitor symptom patterns over time with Optimize. Start free.

Related Articles

• Supplements for Chronic Fatigue: What Helps When You're Always Tired